PARP1 EXPRESSION IS A STRONG PROGNOSTIC BIOMARKER IN MULTIPLE MYELOMA PATIENTS RECEIVING AUTOLOGOUS STEM CELL TRANSPLANT.

被引:0
|
作者
Thomas, M. [1 ]
King, K. [2 ]
Seligson, N. [2 ]
机构
[1] Univ Florida, Orlando, FL USA
[2] Univ Florida, Jacksonville, FL USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P-179
引用
收藏
页码:S52 / S52
页数:1
相关论文
共 50 条
  • [21] Results of autologous stem cell transplant in multiple myeloma patients with renal failure
    Badros, A
    Barlogie, B
    Siegel, E
    Roberts, J
    Langmaid, C
    Zangari, M
    Desikan, R
    Shaver, MJ
    Fassas, A
    McConnell, S
    Muwalla, F
    Barri, Y
    Anaissie, E
    Munshi, N
    Tricot, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (04) : 822 - 829
  • [22] Outcome of Patients with Multiple Myeloma by Ethnicity in the Setting of Autologous Stem Cell Transplant
    Sasaki, Koji
    Bashir, Qaiser
    Shah, Nina
    Hosing, Chitra
    Popat, Uday R.
    Nieto, Yago
    Parmar, Simrit
    Shah, Jatin
    Weber, Donna
    Thomas, Sheeba
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S231 - S232
  • [23] RESULTS OF AUTOLOGOUS STEM CELL TRANSPLANT IN MULTIPLE MYELOMA PATIENTS WITH RENAL FAILURE
    Ben Abdeljelil, N.
    Torjemane, L.
    Lakhal, A.
    Elfatmi, R.
    Ladeb, S.
    Ben Othman, T.
    HAEMATOLOGICA, 2014, 99 : 656 - 656
  • [24] IMPLEMENTATION OF AN EDUCATION INTERVENTION FOR MULTIPLE MYELOMA PATIENTS RECEIVING STEM CELL TRANSPLANT
    Halpin, Sean
    Konomos, Michael
    INNOVATION IN AGING, 2022, 6 : 235 - 235
  • [25] AUTOLOGOUS STEM CELL TRANSPLANT WITH NON CRYOPRESERVED HEMATOPOIETIC STEM CELL IN ALGERIAN PATIENTS WITH MULTIPLE MYELOMA
    Bekadja, A.
    Talhi, S.
    Amani, K.
    Brahimi, M.
    Osmani, S.
    Yafour, N.
    Krim, A.
    Bouhass, R.
    HAEMATOLOGICA, 2016, 101 : 629 - 629
  • [26] Autologous versus allogeneic stem cell transplant for multiple myeloma
    Arora, M
    McGlave, PB
    Burns, LJ
    Miller, JS
    Barker, JN
    Defor, TE
    Weisdorf, DJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 71 - 72
  • [27] Multiple Myeloma: Autologous Stem Cell Transplant in an aging population
    King, Justin
    Fiala, Mark
    Goldsmith, Scott
    Stockerl-Goldstein, Keith
    Schroeder, Mark
    Ghobadi, Armin
    Vij, Ravi
    Wildes, Tanya
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E293 - E294
  • [28] Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Dingli, David
    Gonsalves, Wilson I.
    Kumar, Shaji
    Kapoor, Prashant
    Kourelis, Taxiarchis
    Hogan, William J.
    MAYO CLINIC PROCEEDINGS, 2018, 93 (01) : 56 - 58
  • [29] Safety of therapeutic anticoagulation in patients with multiple myeloma receiving autologous stem cell transplantation
    AD Schimmer
    AK Stewart
    A Keating
    J MacKinnon
    M Crump
    DM Sutton
    FA Shepherd
    J Meharchand
    Bone Marrow Transplantation, 1998, 22 : 491 - 494
  • [30] Safety of therapeutic anticoagulation in patients with multiple myeloma receiving autologous stem cell transplantation
    Schimmer, AD
    Stewart, AK
    Keating, A
    MacKinnon, J
    Crump, M
    Sutton, DM
    Shepherd, FA
    Meharchand, J
    BONE MARROW TRANSPLANTATION, 1998, 22 (05) : 491 - 494